An Observational Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms APOLO
- Sponsors Celgene Corporation
- 28 Sep 2017 Planned End Date changed from 31 May 2018 to 30 Jun 2018.
- 28 Sep 2017 Planned primary completion date changed from 31 May 2018 to 30 Jun 2018.
- 05 May 2017 Status changed from not yet recruiting to recruiting.